The board of directors of AstraZeneca Pharma India will meet on May 5 to consider seeking approval of shareholders of the company through postal ballot, for the voluntary delisting proposed by AstraZeneca Pharmaceuticals AB Sweden, promoter of the company. The stock on Friday closed at ₹1,127.5 on the BSE.
The board of directors of Deepak Nitrite Ltd on Friday approved a 1:1 bonus ratio for the shareholders of the company. The board also approved the sub-division of equity of shares’ face value from ₹10 to ₹2 and a dividend of ₹10 a share of face value of ₹10. The recommendations, however, are subject to the approval of shareholders. Since the record date for the allotment of bonus shares and sub-division of shares will fall prior to the book closure date for the payment of dividend, the shareholders will be entitled to dividend of ₹1 per share of face value of ₹2 each. The stock on Friday closed at ₹532.55, up one per cent over the previous day’s close.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.